<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Surgical treatment of essential tremor</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Surgical treatment of essential tremor</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Surgical treatment of essential tremor</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kelvin L Chou, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Howard I Hurtig, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Tremor is defined as an involuntary, rhythmic, and oscillatory movement of a body part with a relatively constant frequency and variable amplitude. Tremor is the most common type of movement disorder, and essential tremor (ET) is the most common neurologic tremor disorder.</p><p>ET is a clinical syndrome characterized by an action tremor involving both upper limbs of at least three years' duration [<a href="#rid1">1</a>]. Tremor may or may not be present in other locations, such as the head or voice. The legs are usually spared. The classification, detailed clinical features, and diagnosis of ET are reviewed elsewhere. (See  <a class="medical medical_review" href="/d/html/110665.html" rel="external">"Essential tremor: Clinical features and diagnosis"</a>.)</p><p>This topic will review the surgical treatment of ET. The pharmacologic treatment of ET is discussed separately. (See  <a class="medical medical_review" href="/d/html/4898.html" rel="external">"Essential tremor: Treatment and prognosis"</a>.)</p><p class="headingAnchor" id="H215636795"><span class="h1">PATIENT SELECTION</span><span class="headingEndMark"> — </span>The ideal ET surgical candidate has an upper extremity tremor that interferes with the quality of life.</p><p class="headingAnchor" id="H1896696766"><span class="h2">Tremor characteristics</span><span class="headingEndMark"> — </span>Because tremor in ET involves the upper limbs, it affects many daily activities. Common examples include eating, drinking, pouring, writing, typing, texting, doing artwork, and applying makeup. Surgical treatment significantly reduces upper extremity tremor in patients with ET, allowing them to perform such tasks more easily [<a href="#rid2">2-6</a>]. When performed unilaterally, surgical treatment typically targets the dominant hand.</p><p>By contrast, there are limited and conflicting data regarding the effectiveness of surgical approaches for head or voice tremor [<a href="#rid7">7-11</a>]. Therefore, a patient with ET whose main problem is a head or voice tremor is unlikely to be offered surgery. Botulinum toxin injections are used to treat persistently disabling head or vocal cord tremor. (See  <a class="medical medical_review" href="/d/html/4898.html" rel="external">"Essential tremor: Treatment and prognosis", section on 'Botulinum toxin'</a>.)</p><p class="headingAnchor" id="H2214684563"><span class="h2">Failure of medical therapies</span><span class="headingEndMark"> — </span>Prior to considering surgery, patients should have failed adequate trials of the two first-line medication therapies for ET, <a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">propranolol</a> and <a class="drug drug_general" data-topicid="9811" href="/d/drug information/9811.html" rel="external">primidone</a>. Some surgical centers may also require an adequate trial of a second-line therapy before surgical evaluation. (See  <a class="medical medical_review" href="/d/html/4898.html" rel="external">"Essential tremor: Treatment and prognosis", section on 'Second-line therapies'</a>.)</p><p class="headingAnchor" id="H1946267535"><span class="h2">Contraindications</span><span class="headingEndMark"> — </span>Dementia or significant cognitive impairment are considered contraindications to surgical treatment for ET, as they contribute to delirium in the perioperative period and may worsen after surgery. Patients with mild cognitive impairment may be candidates for surgical therapies; most surgical centers use neuropsychological testing to screen for dementia, and this underscores the importance of the multidisciplinary evaluation. Age may increase the risk for cognitive impairment, but there is no evidence that age itself affects surgical outcomes in ET.</p><p>Prior to considering surgical treatment for ET, candidates should be screened for psychiatric illness, such as anxiety and depression. If present and active, centers may opt to delay surgery until the psychiatric symptoms are stabilized.</p><p>Significant medical comorbidities such as diabetes, heart disease, and obesity may increase general surgical risk. Although these comorbidities are not absolute contraindications, they should be carefully considered prior to offering a surgical procedure such as deep brain stimulation (DBS).</p><p class="headingAnchor" id="H2931218198"><span class="h1">MULTIDISCIPLINARY EVALUATION</span><span class="headingEndMark"> — </span>Prospective surgical candidates should undergo a multidisciplinary team evaluation at a specialized center prior to surgery [<a href="#rid12">12</a>]. The multidisciplinary team typically includes a movement disorders neurologist, a functional neurosurgeon, and a neuropsychologist. A psychiatrist, speech therapist, physical therapist, occupational therapist, nurse, and social worker may also be useful members of the team.</p><p>The goals of the multidisciplinary evaluation are to:</p><p class="bulletIndent1"><span class="glyph">●</span>Confirm the diagnosis of ET (see  <a class="medical medical_review" href="/d/html/110665.html" rel="external">"Essential tremor: Clinical features and diagnosis", section on 'Evaluation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Make sure the patient has undergone adequate medication trials (see  <a class="medical medical_review" href="/d/html/4898.html" rel="external">"Essential tremor: Treatment and prognosis", section on 'Treatment approach'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assess surgical risk (see  <a class="medical medical_review" href="/d/html/4816.html" rel="external">"Preoperative medical evaluation of the healthy adult patient"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Screen for cognitive impairment and dementia (see  <a class="medical medical_review" href="/d/html/5083.html" rel="external">"Evaluation of cognitive impairment and dementia", section on 'Cognitive testing'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Educate the patient on realistic expectations as well as risks of the procedure</p><p></p><p>After each member of the team evaluates a potential candidate, the team convenes for a frank discussion about each candidate. If the patient is felt to be appropriate for surgery, the team would then discuss the type of surgery to perform and whether to offer unilateral or bilateral surgery before sharing the consensus opinion with the patient.</p><p class="headingAnchor" id="H3150924426"><span class="h1">PROCEDURE SELECTION</span><span class="headingEndMark"> — </span>Surgical procedures for ET typically target the ventral intermediate (VIM) nucleus of the thalamus. Although the exact origin of tremor generation in ET is not entirely clear, cellular activity in the VIM nucleus of the thalamus is highly related to the tremor itself [<a href="#rid13">13</a>].</p><p>There are two surgical options for patients with medically refractory limb tremor due to ET: thalamic VIM nucleus deep brain stimulation (DBS) and thalamotomy (conventional thalamotomy, gamma knife, or magnetic resonance imaging [MRI]-guided focused ultrasound). Among these, DBS and MRI-guided focused ultrasound thalamotomy are the only two therapies approved by the US Food and Drug Administration (FDA) for treatment of ET.</p><p>The decision of whether to use either DBS or thalamotomy should be individualized and must take into consideration the risk of perioperative complications compared with the feasibility of ongoing stimulator monitoring and programming adjustments [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H1239058758"><span class="h2">Preference for deep brain stimulation</span><span class="headingEndMark"> — </span>For most patients with ET who have persistently disabling limb tremor that is refractory to medical management, DBS in the VIM nucleus of the thalamus is the more regularly chosen therapy, rather than thalamotomy. While both procedures are effective for tremor and there have been limited direct prospective comparisons, we prefer DBS for two main reasons:</p><p class="bulletIndent1"><span class="glyph">●</span>The DBS procedure does not involve destruction of brain tissue, whereas thalamotomy produces a permanent lesion that cannot be reversed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>DBS can be performed bilaterally if needed, whereas bilateral thalamotomy frequently causes significant speech impairment. While bilateral VIM DBS may also cause dysarthria and other adverse effects, stimulation can typically be adjusted to relieve these side effects.</p><p></p><p class="headingAnchor" id="H254180693"><span class="h2">Role of unilateral thalamotomy</span><span class="headingEndMark"> — </span>MRI-guided focused ultrasound is a newer technique that has become available to carry out unilateral thalamotomy. It does not require craniotomy and does not use radiation, which gives it relative advantages over other forms of thalamotomy.</p><p>As experience with focused ultrasound thalamotomy accumulates at specialized centers, it is becoming a reasonable alternative for refractory ET if DBS is not available or practical due to age, other medical issues, or poor access to DBS centers for ongoing stimulator monitoring and adjustments. More long-term outcome information for this technique is still needed, however.</p><p>Conventional unilateral thalamotomy has largely been replaced by DBS for the reasons discussed above. (See <a class="local">'Preference for deep brain stimulation'</a> above.)</p><p class="headingAnchor" id="H6"><span class="h1">DEEP BRAIN STIMULATION</span></p><p class="headingAnchor" id="H44958957"><span class="h2">Device implantation and programming</span><span class="headingEndMark"> — </span>When used to treat ET, deep brain stimulation (DBS) typically involves the implantation of an electrode (or lead) with four or more contacts in the thalamic ventral intermediate (VIM) nucleus using stereotactic methods [<a href="#rid2">2,14</a>]. More limited data are available for stimulation of the posterior subthalamic area (PSA). (See <a class="local">'Other stimulation targets'</a> below.)</p><p>The implanted lead is connected via a connecting wire to a pulse generator implanted in the chest wall below the clavicle (similar to a permanent pacemaker). When turned on, the pulse generator delivers high-frequency electrical stimulation through one or more contacts in the lead.</p><p>Programming of the pulse generator to optimize the electrode configuration, voltage, pulse frequency, and pulse width is typically done by a member of the treatment team with a handheld device. The initial DBS programming visit usually occurs a few weeks after implantation. During this visit, each contact is tested for its ability to reduce tremor in the contralateral upper extremity, while observing for side effects. The effect of stimulation on tremor can be seen quickly, sometimes within seconds. The contact with the settings that provide the greatest benefit with the fewest side effects is selected for stimulation.</p><p>Since there is no universal formula for programming, each patient must participate in the transaction to inform the programmer when the best settings have been achieved. Follow-up visits to optimize the stimulator settings may initially be frequent, depending upon the clinical response. Stable settings are usually achieved after a few months of programming.</p><p>Once stable settings are achieved, regular follow-up visits for programming checks (once every 6 to 12 months) are necessary to maintain the best clinical benefit and to monitor battery life (typically three to five years) [<a href="#rid15">15</a>]. Patients who require extremely high stimulator settings to control tremor may find that the battery drains more quickly (eg, less than two years). Pulse generators with a rechargeable battery are now readily available, and their use would eliminate the need for frequent pulse generator replacements. </p><p class="headingAnchor" id="H8"><span class="h2">Ventral intermediate nucleus stimulation</span><span class="headingEndMark"> — </span>Evidence-based guidelines from the American Academy of Neurology (AAN) conclude that DBS of the thalamic VIM nucleus is effective in reducing contralateral limb tremor in ET [<a href="#rid2">2,3</a>]. VIM DBS should not generally be performed for head or voice tremor in patients with ET, as the experience to date suggests that with unilateral stimulation, these tremors are not meaningfully improved by DBS in most patients. Bilateral VIM stimulation may improve head or voice tremor in some patients, but is also more likely to cause dysarthria than unilateral stimulation.</p><p class="headingAnchor" id="H765347685"><span class="h3">Outcomes</span><span class="headingEndMark"> — </span>In short-term prospective open-label and blinded evaluation trials of VIM DBS in patients with ET, the mean relative improvement in contralateral postural and kinetic limb tremor from baseline is between 60 to 90 percent when measured within a year of implantation [<a href="#rid4">4,5,10,16-18</a>]. VIM DBS also improves disability and health-related quality of life [<a href="#rid16">16-18</a>].</p><p>Tremor improvement can even be maintained beyond 10 years, although the long-term mean contralateral limb tremor improvement may drop to approximately 50 percent [<a href="#rid19">19-22</a>]. The decrease in effectiveness of DBS over the long term has been attributed to progression of the disease but may also reflect some degree of habituation to stimulation [<a href="#rid23">23</a>].</p><p>Occasionally, patients may have unsatisfactory results from DBS. In such cases, referral to an experienced DBS center is recommended for evaluation and management. There may be several reasons for these DBS "failures," the most common of which are inadequate programming, suboptimal lead placement, and hardware-related complications. In a retrospective case series of 41 movement disorder patients (ET, Parkinson disease, and dystonia) referred to two DBS centers because of poor results from DBS, 51 percent ultimately had good outcomes after lead revision, reprogramming of the stimulator, or medication adjustments [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H840665564"><span class="h3">Complications</span><span class="headingEndMark"> — </span>Complications of DBS may be surgery related, device related, or stimulation related.</p><p>General operative risks of brain surgery include perioperative confusion, headache, ischemia, and seizures. The risk of hemorrhage secondary to electrode implantation is approximately 1 percent in patients undergoing thalamic DBS for ET [<a href="#rid25">25</a>].</p><p>Device-related complications, such as equipment malfunction, lead breakage, infection, or lead migration, have occurred in up to 15 percent of all DBS patients depending on the series [<a href="#rid2">2,26</a>].</p><p>Stimulation-related adverse effects include dysarthria, contralateral face and/or limb paresthesias, imbalance and gait instability, and dystonia. Paresthesias in the contralateral face and limb are commonly experienced when turning the stimulator on or when increasing stimulation, but they are mostly transient, lasting a few seconds before resolving. Dysarthria, dystonia, and gait instability are less common than paresthesias and often resolve with adjustment of stimulator parameters.</p><p class="headingAnchor" id="H3071064260"><span class="h3">Unilateral versus bilateral stimulation</span><span class="headingEndMark"> — </span>Since unilateral DBS suppresses only contralateral limb tremor, bilateral thalamic DBS is needed to suppress bilateral upper limb tremor. However, bilateral thalamic stimulation is associated with a greater risk of hemorrhage and more stimulation-related side effects, in particular dysarthria and gait instability, than unilateral stimulation [<a href="#rid2">2,3,5,27</a>].</p><p>The decision as to whether to offer unilateral or bilateral thalamic DBS should be made after discussion of the relative risks and benefits between the multidisciplinary team and the patient. Some DBS centers will perform unilateral thalamic DBS for disabling tremor in the dominant hand initially and then implant a contralateral thalamic DBS lead for tremor in the other hand later if unilateral DBS does not provide sufficient improvement in quality of life.</p><p class="headingAnchor" id="H2657106162"><span class="h2">Other stimulation targets</span><span class="headingEndMark"> — </span>VIM nucleus stimulation works very well for limb tremor in ET and is the only target approved by the US Food and Drug Administration (FDA) for ET. However, occasional patients have tremor that does not respond to VIM stimulation, and other targets are being explored.</p><p>Posterior subthalamic area (PSA) stimulation is one example. A couple of crossover trials have placed DBS leads in a position that allows dorsal contacts to stimulate the VIM nucleus and ventral contacts to stimulate the PSA [<a href="#rid28">28-30</a>]. These trials have suggested that tremor control is slightly better with PSA DBS compared with VIM DBS, but a comparative trial targeting the two targets separately is needed.</p><p class="headingAnchor" id="H97904254"><span class="h1">UNILATERAL THALAMOTOMY</span><span class="headingEndMark"> — </span>There are three types of thalamotomy procedures: conventional, gamma knife, and MRI-guided focused ultrasound. All of these procedures create a permanent lesion in the ventral intermediate (VIM) nucleus of the thalamus to treat contralateral limb tremor.</p><p>Bilateral thalamotomy is not routinely performed for ET as conventional bilateral thalamotomy was associated with an unacceptably high rate of side effects, particularly impairment of speech articulation [<a href="#rid2">2</a>]. However, there are ongoing trials of bilateral thalamotomy using MRI-guided focused ultrasound. </p><p class="headingAnchor" id="H3201111627"><span class="h2">Conventional thalamotomy</span><span class="headingEndMark"> — </span>Conventional unilateral thalamotomy is similar to DBS in that it uses stereotactic surgical and electrophysiologic techniques to locate the VIM nucleus of the thalamus. Patients are placed in an operating head frame and a burr hole is drilled in the skull. A probe is guided into the thalamus, where radiofrequency is used to create a lesion. This method has essentially been replaced by DBS, since DBS does not create a permanent lesion. (See <a class="local">'Preference for deep brain stimulation'</a> above.)</p><p>Limited data from older open-label trials suggest that unilateral thalamotomy is effective for treating contralateral limb tremor associated with ET, reducing tremor severity in 80 to 90 percent of patients, which can be maintained long term [<a href="#rid2">2,31-33</a>]. Adverse effects associated with thalamotomy occur in approximately 14 to 47 percent of patients, and persistent adverse events occur in approximately 16 percent [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H3142363879"><span class="h2">MRI-guided focused ultrasound thalamotomy</span><span class="headingEndMark"> — </span>MRI-guided focused ultrasound thalamotomy has received regulatory approval in the United States and Europe for treatment of refractory ET. As discussed above, it is a reasonable alternative to DBS in selected patients, although longer-term follow-up data are still needed (see <a class="local">'Role of unilateral thalamotomy'</a> above). The technique uses high-energy ultrasound beams to create a lesion in the VIM nucleus of the thalamus. Although MRI-guided focused ultrasound has been marketed as "noninvasive," meaning it does not require craniotomy, it should actually be considered an invasive procedure, as brain tissue is destroyed. Electrophysiologic guidance is not possible with this approach.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unilateral lesioning</strong> – Regulatory approval was based on short-term results of a multicenter trial in which 76 patients with medically refractory ET were randomly assigned in a 3:1 ratio to focused ultrasound thalamotomy (producing unilateral thermal ablation of the thalamic VIM nucleus) or to a sham procedure [<a href="#rid6">6</a>]. At three months, the thalamotomy group had significantly greater improvement in hand tremor scores compared with the sham treatment group; the between-group difference in the mean change from baseline was 8.3 points (95% CI 5.9-10.7) and was maintained at 12 months (7.2 points, 95% CI 6.1-8.3). The thalamotomy group also had significant improvements in scores assessing disability and quality of life. Of some concern, tremor scores in the thalamotomy group increased slightly from 3 to 12 months, suggesting possible gradual loss of efficacy [<a href="#rid34">34</a>]. Adverse events at three months were more common in the thalamotomy group, including gait disturbance in 36 percent and numbness or paresthesia in 38 percent; these persisted at 12 months in 9 and 14 percent, respectively [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">With further follow-up of the trial participants, including 19 of 20 patients in the sham group who were actively treated after the three-month blinded period, initial benefits were sustained in most patients at three and five years of follow-up, although confidence is limited by a high rate of loss to follow-up over time (eg, only 40 out of 75 treated patients completing follow-up assessments at five years) and rare crossover to other therapies (eg, deep brain stimulation [DBS] in four patients) [<a href="#rid34">34-37</a>]. Compared with preprocedure baseline scores, the improvement in postprocedure tremor scores remained stable over 60 months in patients who were available for follow-up examinations. No new adverse events emerged, and two patients with persistent paresthesias or ataxia at 12 months reported resolution of symptoms at 24 months.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bilateral lesioning</strong> – In a phase 2 trial of 10 patients with ET who underwent bilateral MRI-guided focused ultrasound but with a smaller lesion on the second side, tremor severity and quality of life were improved at three months [<a href="#rid38">38</a>]. Only one patient reported speech difficulty, although two patients had mild dysphagia at three months. Two patients had transient gait problems that resolved by three months. These results suggest that bilateral thalamotomy (with a smaller lesion on the second side) using MRI guided-focused ultrasound is reasonably safe, but further studies are needed. </p><p></p><p class="headingAnchor" id="H3555713000"><span class="h2">Other techniques</span><span class="headingEndMark"> — </span>Stereotactic radiosurgery is a noninvasive technique in which a single high dose of radiation is delivered in a highly focused way to an MRI-defined target in the brain. In the case of ET, the target is the VIM nucleus of the thalamus. (See  <a class="medical medical_review" href="/d/html/7063.html" rel="external">"Stereotactic cranial radiosurgery"</a>.)</p><p>Unilateral stereotactic radiosurgery thalamotomy delivered by gamma knife or other modalities has been reported to improve tremor in 75 to 90 percent of patients, but clinical improvement is delayed for weeks to months following the procedure [<a href="#rid2">2,39-41</a>]. Neurologic complications include transient or permanent hemiparesis, dysphagia, and transient/sustained facial sensory loss.</p><p>Radiosurgery thalamotomy has not generally been adopted for ET due to concerns about delayed radiation side effects, including risk of radiation necrosis and a theoretical risk of secondary tumor formation [<a href="#rid2">2,3</a>].</p><p class="headingAnchor" id="H3250832110"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118682.html" rel="external">"Society guideline links: Essential tremor"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/16194.html" rel="external">"Patient education: Tremor (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/733.html" rel="external">"Patient education: Tremor (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2400785862"><span class="h1">PATIENT PERSPECTIVE TOPICS</span><span class="headingEndMark"> — </span>Patient perspectives are provided for selected disorders to help clinicians better understand the patient experience and patient concerns. These narratives may offer insights into patient values and preferences not included in other UpToDate topics. (See  <a class="medical medical_review" href="/d/html/141104.html" rel="external">"Patient perspective: Essential tremor with onset in childhood"</a> and  <a class="medical medical_review" href="/d/html/141156.html" rel="external">"Patient perspective: An artist with essential tremor"</a>.)</p><p class="headingAnchor" id="H13"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient selection</strong> – Before considering surgical intervention, patients with essential tremor (ET) should have adequate trials of at least the two first-line therapies for ET, <a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">propranolol</a> and <a class="drug drug_general" data-topicid="9811" href="/d/drug information/9811.html" rel="external">primidone</a>. Some surgical centers may also require failure of a second-line agent before surgical evaluation. (See <a class="local">'Failure of medical therapies'</a> above and  <a class="medical medical_review" href="/d/html/4898.html" rel="external">"Essential tremor: Treatment and prognosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multidisciplinary evaluation</strong> – Prospective candidates should undergo a multidisciplinary team evaluation at a specialized center. Procedure selection is individualized and should consider the risk of perioperative complications compared with the feasibility of ongoing stimulator monitoring and adjustments. (See <a class="local">'Multidisciplinary evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedure selection</strong> – Surgical options for disabling limb tremor due to ET include deep brain stimulation (DBS) in the ventral intermediate (VIM) nucleus of the thalamus and unilateral thalamotomy with MRI-guided focused ultrasound. Botulinum toxin injections into neck muscles or vocal cords can be used to treat persistently disabling head or vocal cord tremor. (See <a class="local">'Procedure selection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most patients with ET who have persistently disabling unilateral or bilateral limb tremor that is refractory to medical management, we suggest surgical treatment with DBS over thalamotomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Compared with thalamotomy, DBS does not produce a permanent lesion, can be performed bilaterally if deemed necessary, and allows for future adjustments if these should become necessary over time. (See <a class="local">'Preference for deep brain stimulation'</a> above and <a class="local">'Outcomes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unilateral thalamotomy with MRI-guided focused ultrasound is a reasonable alternative for treating contralateral limb tremor associated with ET. This is the only form of thalamotomy approved for ET by the US Food and Drug Administration (FDA), although data on long-term durability remain limited. (See <a class="local">'MRI-guided focused ultrasound thalamotomy'</a> above.)</p><p></p><p class="headingAnchor" id="H2089578135"><span class="h1">ACKNOWLEDGMENTS</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Ludy Shih, MD, and Daniel Tarsy, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bhatia KP, Bain P, Bajaj N, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 2018; 33:75.</a></li><li><a class="nounderline abstract_t">Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005; 64:2008.</a></li><li><a class="nounderline abstract_t">Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology 2011; 77:1752.</a></li><li><a class="nounderline abstract_t">Koller W, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997; 42:292.</a></li><li><a class="nounderline abstract_t">Pahwa R, Lyons KL, Wilkinson SB, et al. Bilateral thalamic stimulation for the treatment of essential tremor. Neurology 1999; 53:1447.</a></li><li><a class="nounderline abstract_t">Elias WJ, Lipsman N, Ondo WG, et al. A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. N Engl J Med 2016; 375:730.</a></li><li><a class="nounderline abstract_t">Carpenter MA, Pahwa R, Miyawaki KL, et al. Reduction in voice tremor under thalamic stimulation. Neurology 1998; 50:796.</a></li><li><a class="nounderline abstract_t">Taha JM, Janszen MA, Favre J. Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. J Neurosurg 1999; 91:68.</a></li><li><a class="nounderline abstract_t">Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry 1999; 66:289.</a></li><li><a class="nounderline abstract_t">Ondo W, Jankovic J, Schwartz K, et al. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology 1998; 51:1063.</a></li><li><a class="nounderline abstract_t">Koller WC, Lyons KE, Wilkinson SB, Pahwa R. Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor. Mov Disord 1999; 14:847.</a></li><li><a class="nounderline abstract_t">Shah N, Leventhal D, Persad C, et al. A suggested minimum standard deep brain stimulation evaluation for essential tremor. J Neurol Sci 2016; 362:165.</a></li><li><a class="nounderline abstract_t">Haubenberger D, Hallett M. Essential Tremor. N Engl J Med 2018; 378:1802.</a></li><li><a class="nounderline abstract_t">Flora ED, Perera CL, Cameron AL, Maddern GJ. Deep brain stimulation for essential tremor: a systematic review. Mov Disord 2010; 25:1550.</a></li><li><a class="nounderline abstract_t">Hubble JP, Busenbark KL, Wilkinson S, et al. Deep brain stimulation for essential tremor. Neurology 1996; 46:1150.</a></li><li><a class="nounderline abstract_t">Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry 2005; 76:1188.</a></li><li><a class="nounderline abstract_t">Hariz GM, Blomstedt P, Koskinen LO. Long-term effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life. Acta Neurol Scand 2008; 118:387.</a></li><li><a class="nounderline abstract_t">Cury RG, Fraix V, Castrioto A, et al. Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia. Neurology 2017; 89:1416.</a></li><li><a class="nounderline abstract_t">Koller WC, Lyons KE, Wilkinson SB, et al. Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord 2001; 16:464.</a></li><li><a class="nounderline abstract_t">Rehncrona S, Johnels B, Widner H, et al. Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments. Mov Disord 2003; 18:163.</a></li><li><a class="nounderline abstract_t">Favilla CG, Ullman D, Wagle Shukla A, et al. Worsening essential tremor following deep brain stimulation: disease progression versus tolerance. Brain 2012; 135:1455.</a></li><li><a class="nounderline abstract_t">Tsuboi T, Jabarkheel Z, Zeilman PR, et al. Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremor. Neurology 2020; 94:e1073.</a></li><li><a class="nounderline abstract_t">Paschen S, Forstenpointner J, Becktepe J, et al. Long-term efficacy of deep brain stimulation for essential tremor: An observer-blinded study. Neurology 2019; 92:e1378.</a></li><li><a class="nounderline abstract_t">Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005; 62:1250.</a></li><li><a class="nounderline abstract_t">Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005; 56:722.</a></li><li><a class="nounderline abstract_t">Baizabal Carvallo JF, Simpson R, Jankovic J. Diagnosis and treatment of complications related to deep brain stimulation hardware. Mov Disord 2011; 26:1398.</a></li><li><a class="nounderline abstract_t">Ondo W, Almaguer M, Jankovic J, Simpson RK. Thalamic deep brain stimulation: comparison between unilateral and bilateral placement. Arch Neurol 2001; 58:218.</a></li><li><a class="nounderline abstract_t">Blomstedt P, Sandvik U, Tisch S. Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor. Mov Disord 2010; 25:1350.</a></li><li><a class="nounderline abstract_t">Barbe MT, Reker P, Hamacher S, et al. DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial. Neurology 2018; 91:e543.</a></li><li><a class="nounderline abstract_t">Kvernmo N, Konglund AE, Reich MM, et al. Deep Brain Stimulation for Arm Tremor: A Randomized Trial Comparing Two Targets. Ann Neurol 2022; 91:585.</a></li><li><a class="nounderline abstract_t">Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 1995; 37:680.</a></li><li><a class="nounderline abstract_t">Mohadjer M, Goerke H, Milios E, et al. Long-term results of stereotaxy in the treatment of essential tremor. Stereotact Funct Neurosurg 1990; 54-55:125.</a></li><li><a class="nounderline abstract_t">Nagaseki Y, Shibazaki T, Hirai T, et al. Long-term follow-up results of selective VIM-thalamotomy. J Neurosurg 1986; 65:296.</a></li><li><a class="nounderline abstract_t">Louis ED. Treatment of Medically Refractory Essential Tremor. N Engl J Med 2016; 375:792.</a></li><li><a class="nounderline abstract_t">Chang JW, Park CK, Lipsman N, et al. A prospective trial of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: Results at the 2-year follow-up. Ann Neurol 2018; 83:107.</a></li><li><a class="nounderline abstract_t">Halpern CH, Santini V, Lipsman N, et al. Three-year follow-up of prospective trial of focused ultrasound thalamotomy for essential tremor. Neurology 2019; 93:e2284.</a></li><li><a class="nounderline abstract_t">Cosgrove GR, Lipsman N, Lozano AM, et al. Magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor: 5-year follow-up results. J Neurosurg 2023; 138:1028.</a></li><li><a class="nounderline abstract_t">Iorio-Morin C, Yamamoto K, Sarica C, et al. Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST-FUS Phase 2 Trial). Mov Disord 2021; 36:2653.</a></li><li><a class="nounderline abstract_t">Niranjan A, Kondziolka D, Baser S, et al. Functional outcomes after gamma knife thalamotomy for essential tremor and MS-related tremor. Neurology 2000; 55:443.</a></li><li><a class="nounderline abstract_t">Young RF, Jacques S, Mark R, et al. Gamma knife thalamotomy for treatment of tremor: long-term results. J Neurosurg 2000; 93 Suppl 3:128.</a></li><li><a class="nounderline abstract_t">Khattab MH, Cmelak AJ, Sherry AD, et al. Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery. Int J Radiat Oncol Biol Phys 2022; 112:121.</a></li></ol></div><div id="topicVersionRevision">Topic 4901 Version 35.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29193359" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15972843" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22013182" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9307249" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10534249" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bilateral thalamic stimulation for the treatment of essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27557301" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9521280" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Reduction in voice tremor under thalamic stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10389882" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10084526" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9781530" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10495050" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26944141" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : A suggested minimum standard deep brain stimulation evaluation for essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29742376" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Essential Tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20623768" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Deep brain stimulation for essential tremor: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8780109" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Deep brain stimulation for essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16107348" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The effect of deep brain stimulation on quality of life in movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18616684" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Long-term effect of deep brain stimulation for essential tremor on activities of daily living and health-related quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28768840" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11391740" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12539209" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Long-term efficacy of thalamic deep brain stimulation for tremor: double-blind assessments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22344584" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32047071" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30787161" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Long-term efficacy of deep brain stimulation for essential tremor: An observer-blinded study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15956104" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15792511" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21714001" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Diagnosis and treatment of complications related to deep brain stimulation hardware.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11176959" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Thalamic deep brain stimulation: comparison between unilateral and bilateral placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20544817" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Deep brain stimulation in the posterior subthalamic area in the treatment of essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29970404" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35148020" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Deep Brain Stimulation for Arm Tremor: A Randomized Trial Comparing Two Targets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8559296" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2080326" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Long-term results of stereotaxy in the treatment of essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3734879" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Long-term follow-up results of selective VIM-thalamotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27557307" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Treatment of Medically Refractory Essential Tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29265546" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A prospective trial of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: Results at the 2-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31748250" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Three-year follow-up of prospective trial of focused ultrasound thalamotomy for essential tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35932269" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor: 5-year follow-up results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34288097" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST-FUS Phase 2 Trial).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10932286" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Functional outcomes after gamma knife thalamotomy for essential tremor and MS-related tremor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11143229" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Gamma knife thalamotomy for treatment of tremor: long-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34454047" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
